Fasting Blood Glucose Linked to Mortality Outcomes in Patients With COVID-19
Researchers assessed the relationship between fasting blood glucose levels and the risk of mortality in patients hospitalized with COVID-19.
Researchers assessed the relationship between fasting blood glucose levels and the risk of mortality in patients hospitalized with COVID-19.
Investigators compared treatment with interleukin-6 inhibitors with standard of care among patients hospitalized with COVID-19 infection.
Researchers evaluated the effect of adjuvant colchicine with standard therapy among patients with moderate and severe COVID-19 infection.
In this meta-analysis, researchers assessed whether an increase in pancreatic enzymes is associated with an increased risk for severe disease and poor outcomes in patients with COVID-19 infection.
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Investigators conducted a study to determine whether early antibiotic administration decreases the risk for progression to septic shock among patients with suspected sepsis.
Expert calls Pennsylvania’s hospital strike teams short-sighted and a distraction from urgently needed evidence-based policy actions to improve nurse staffing issues.
Investigators assessed whether daily bathing with 2% chlorhexidine gluconate decreases the risk for vancomycin-resistant enterococci (VRE) transmission in an intensive care unit with increased VRE endemicity.
Investigators conducted a meta-analysis of 3 randomized controlled trials that compared the clinical safety and efficacy of janus kinase inhibitors with placebo or standard care for the treatment of patients with COVID-19.